Coherus BioSciences, Inc. (CHRS)
USD 0.78
(-4.73%)
USD 0.78
(-4.73%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 823.02 Million USD | 33.12% |
| 2022 | 618.26 Million USD | 6.3% |
| 2021 | 581.6 Million USD | 3.73% |
| 2020 | 560.67 Million USD | 84.61% |
| 2019 | 303.71 Million USD | 119.99% |
| 2018 | 138.05 Million USD | 4.53% |
| 2017 | 132.07 Million USD | -17.0% |
| 2016 | 159.13 Million USD | -27.44% |
| 2015 | 219.31 Million USD | 82.06% |
| 2014 | 120.46 Million USD | 34.1% |
| 2013 | 89.82 Million USD | 418.02% |
| 2012 | 17.34 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 845.38 Million USD | 2.72% |
| 2024 Q2 | 758.96 Million USD | -10.22% |
| 2023 Q4 | 823.02 Million USD | 14.73% |
| 2023 Q2 | 644.35 Million USD | 7.58% |
| 2023 Q1 | 598.93 Million USD | -3.13% |
| 2023 Q3 | 717.38 Million USD | 11.33% |
| 2023 FY | 823.02 Million USD | 33.12% |
| 2022 Q3 | 648.04 Million USD | 13.96% |
| 2022 Q4 | 618.26 Million USD | -4.59% |
| 2022 FY | 618.26 Million USD | 6.3% |
| 2022 Q1 | 580.82 Million USD | -0.13% |
| 2022 Q2 | 568.63 Million USD | -2.1% |
| 2021 Q2 | 583.32 Million USD | 3.13% |
| 2021 Q4 | 581.6 Million USD | -4.81% |
| 2021 FY | 581.6 Million USD | 3.73% |
| 2021 Q3 | 610.96 Million USD | 4.74% |
| 2021 Q1 | 565.63 Million USD | 0.88% |
| 2020 Q1 | 309.26 Million USD | 1.83% |
| 2020 FY | 560.67 Million USD | 84.61% |
| 2020 Q4 | 560.67 Million USD | 2.31% |
| 2020 Q3 | 548 Million USD | 0.88% |
| 2020 Q2 | 543.23 Million USD | 75.65% |
| 2019 FY | 303.71 Million USD | 119.99% |
| 2019 Q1 | 224.63 Million USD | 62.71% |
| 2019 Q2 | 244.44 Million USD | 8.82% |
| 2019 Q3 | 271.36 Million USD | 11.01% |
| 2019 Q4 | 303.71 Million USD | 11.92% |
| 2018 Q4 | 138.05 Million USD | 6.97% |
| 2018 FY | 138.05 Million USD | 4.53% |
| 2018 Q3 | 129.06 Million USD | 2.04% |
| 2018 Q2 | 126.48 Million USD | -3.85% |
| 2018 Q1 | 131.55 Million USD | -0.4% |
| 2017 Q3 | 134.85 Million USD | -4.63% |
| 2017 Q2 | 141.39 Million USD | -6.07% |
| 2017 Q1 | 150.53 Million USD | -5.4% |
| 2017 FY | 132.07 Million USD | -17.0% |
| 2017 Q4 | 132.07 Million USD | -2.06% |
| 2016 FY | 159.13 Million USD | -27.44% |
| 2016 Q2 | 313.04 Million USD | 6.8% |
| 2016 Q4 | 159.13 Million USD | -0.94% |
| 2016 Q1 | 293.11 Million USD | 33.65% |
| 2016 Q3 | 160.63 Million USD | -48.69% |
| 2015 Q3 | 162.27 Million USD | 5.93% |
| 2015 Q2 | 153.18 Million USD | 33.02% |
| 2015 Q1 | 115.16 Million USD | -4.4% |
| 2015 FY | 219.31 Million USD | 82.06% |
| 2015 Q4 | 219.31 Million USD | 35.15% |
| 2014 Q4 | 120.46 Million USD | 0.38% |
| 2014 Q2 | 107.6 Million USD | 42.24% |
| 2014 Q1 | 75.65 Million USD | -15.78% |
| 2014 FY | 120.46 Million USD | 34.1% |
| 2014 Q3 | 120 Million USD | 11.52% |
| 2013 Q4 | 89.82 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 89.82 Million USD | 418.02% |
| 2012 FY | 17.34 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -145.113% |
| Alkermes plc | 933.53 Million USD | 11.838% |
| Agenus Inc. | 462.29 Million USD | -78.031% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 79.681% |
| Aptorum Group Limited | 5.25 Million USD | -15556.649% |
| Ardelyx, Inc. | 130.76 Million USD | -529.405% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -72.041% |
| Bicycle Therapeutics plc | 224.41 Million USD | -266.749% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -532.078% |
| ChromaDex Corporation | 26.5 Million USD | -3004.833% |
| Chimerix, Inc. | 19.74 Million USD | -4068.291% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2239.672% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1034.164% |
| CRISPR Therapeutics AG | 346.76 Million USD | -137.343% |
| Precision BioSciences, Inc. | 140.92 Million USD | -484.04% |
| Dyadic International, Inc. | 2.34 Million USD | -35062.397% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -4960.745% |
| Fortress Biotech, Inc. | 165.93 Million USD | -395.983% |
| Lantern Pharma Inc. | 2.73 Million USD | -29941.041% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1051.412% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -23223.693% |
| Incyte Corporation | 1.59 Billion USD | 48.311% |
| IO Biotech, Inc. | 17.55 Million USD | -4588.021% |
| Jaguar Health, Inc. | 45.86 Million USD | -1694.421% |
| Novavax, Inc. | 2.57 Billion USD | 68.004% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2182.514% |
| Opthea Limited | 264.6 Million USD | -211.045% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -529.675% |
| ContextLogic Inc. | 206 Million USD | -299.529% |
| MiMedx Group, Inc. | 96.33 Million USD | -754.385% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1613.858% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -23222.623% |
| NextCure, Inc. | 14.99 Million USD | -5387.958% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -20261.925% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -12226.329% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1660.904% |
| Vaxcyte, Inc. | 167.44 Million USD | -391.51% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2374.595% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -249.906% |
| Pharming Group N.V. | 244.07 Million USD | -237.206% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -6803.447% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -544.043% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -12356.398% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -12356.398% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -898.422% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -12289.417% |
| Acelyrin, Inc. | 86.35 Million USD | -853.098% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -63246.908% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -5623.826% |
| Summit Therapeutics Inc. | 125.25 Million USD | -557.072% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -8582.656% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1465.557% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1096.663% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -443.21% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -41977.147% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -61524.078% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -262.836% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -8686.474% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -261.858% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -66.434% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -7441.039% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2891.636% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -6699.252% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -69.138% |
| Immix Biopharma, Inc. | 3.72 Million USD | -22013.836% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -2076.634% |
| MEI Pharma, Inc. | 8.35 Million USD | -9750.736% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2736.564% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -136.788% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -464.225% |
| Fortress Biotech, Inc. | 165.93 Million USD | -395.983% |
| Precigen, Inc. | 41.64 Million USD | -1876.345% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1548.366% |
| AlloVir, Inc. | 45.01 Million USD | -1728.344% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -531.462% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -497.263% |
| ImmuCell Corporation | 18.81 Million USD | -4274.318% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2815.854% |
| Onconetix, Inc. | 23.18 Million USD | -3450.464% |
| PureTech Health plc | 125.58 Million USD | -555.367% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -9095.855% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2300.761% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -33561.718% |
| Seer, Inc. | 39.36 Million USD | -1990.763% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1231.03% |
| Innoviva, Inc. | 568.55 Million USD | -44.759% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2922.73% |
| ESSA Pharma Inc. | 3.49 Million USD | -23448.277% |
| GlycoMimetics, Inc. | 6.9 Million USD | -11824.372% |
| GT Biopharma, Inc. | 6.63 Million USD | -12308.096% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -211.294% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -202.265% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -879.493% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -8320.595% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2929.294% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -25414.164% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1015.714% |
| Aptose Biosciences Inc. | 15.8 Million USD | -5106.177% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -7355.185% |
| Soligenix, Inc. | 7.27 Million USD | -11213.263% |
| Century Therapeutics, Inc. | 175.94 Million USD | -367.787% |
| Kura Oncology, Inc. | 51.66 Million USD | -1493.103% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -578.608% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -19813.598% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -12344.013% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -225.826% |
| Autolus Therapeutics plc | 263.9 Million USD | -211.863% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -7751.832% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -826.198% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1654.897% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -133.248% |
| GRI Bio, Inc. | 2.69 Million USD | -30416.463% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -101560.604% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2547.162% |
| IGM Biosciences, Inc. | 220.17 Million USD | -273.803% |
| INmune Bio, Inc. | 18.86 Million USD | -4263.424% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -220.895% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2989.238% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -30176.162% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -24990.313% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1307.97% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -755.904% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -210.888% |
| Verastem, Inc. | 71.18 Million USD | -1056.183% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1573.64% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -2033.415% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1581.985% |
| Histogen Inc. | 5.69 Million USD | -14346.709% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -18666.601% |
| Surrozen, Inc. | 8.14 Million USD | -10004.715% |
| Organovo Holdings, Inc. | 2.74 Million USD | -29850.109% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -262129.734% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1363.686% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -4884.43% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1510.53% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -99434.875% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -549.461% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -7511.062% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -445.453% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -31465.788% |
| Apollomics, Inc. | 14.15 Million USD | -5715.226% |
| Amarin Corporation plc | 279.58 Million USD | -194.373% |
| Mesoblast Limited | 188.79 Million USD | -335.931% |
| Turnstone Biologics Corp. | 14.14 Million USD | -5717.282% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -355.245% |
| Synaptogenix, Inc. | 5.52 Million USD | -14784.413% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -12280.099% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -383.827% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -9517.979% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -46732.382% |
| Exelixis, Inc. | 678.44 Million USD | -21.311% |
| Better Therapeutics, Inc. | 23.84 Million USD | -3352.013% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -401.706% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -38.508% |
| NLS Pharmaceutics AG | 10.68 Million USD | -7606.117% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -50591.112% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -2014.288% |
| Gritstone bio, Inc. | 125.91 Million USD | -553.618% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -5507.993% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -16073.891% |
| Avid Bioservices, Inc. | 275.66 Million USD | -198.558% |
| Insmed Incorporated | 1.66 Billion USD | 50.472% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -10596.99% |
| MediWound Ltd. | 27.18 Million USD | -2927.289% |
| OmniAb, Inc. | 87.4 Million USD | -841.681% |
| Alector, Inc. | 487.66 Million USD | -68.768% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -103.995% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -4366.915% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -2044.813% |
| Zai Lab Limited | 240.17 Million USD | -242.676% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -30.627% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2715.989% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -765.645% |
| Immunic, Inc. | 25.36 Million USD | -3144.359% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1088.73% |
| Veracyte, Inc. | 93.71 Million USD | -778.188% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -31353.261% |
| FibroGen, Inc. | 585.72 Million USD | -40.514% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -4634.678% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -125923.464% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -14452.827% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 89.25% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -9939.388% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -879.54% |
| TG Therapeutics, Inc. | 169.08 Million USD | -386.755% |
| Galecto, Inc. | 5.89 Million USD | -13859.108% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -9835.164% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 68.567% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2755.558% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -6421.108% |
| XBiotech Inc. | 8.39 Million USD | -9701.465% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -5507.993% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1447.629% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -126.664% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2961.408% |
| Theravance Biopharma, Inc. | 169 Million USD | -386.988% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 32.294% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -64.466% |
| Vaxxinity, Inc. | 30.94 Million USD | -2559.737% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 15.369% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -13546.4% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -10.439% |
| NexImmune, Inc. | 5.08 Million USD | -16087.873% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -221505.357% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -26666.494% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 88.42% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -15868.65% |
| Scopus BioPharma Inc. | 7.45 Million USD | -10940.798% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -3030.102% |
| Ainos, Inc. | 7.39 Million USD | -11030.703% |
| Pluri Inc. | 34.11 Million USD | -2312.726% |
| Prothena Corporation plc | 135.01 Million USD | -509.574% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -238.552% |
| Celularity Inc. | 102.92 Million USD | -699.608% |
| Rallybio Corporation | 9.43 Million USD | -8622.223% |
| Cue Biopharma, Inc. | 24.44 Million USD | -3266.86% |
| MeiraGTx Holdings plc | 319.99 Million USD | -157.204% |
| Omeros Corporation | 403.25 Million USD | -104.098% |
| Humacyte, Inc. | 114.67 Million USD | -617.693% |
| Immunocore Holdings plc | 228.15 Million USD | -260.728% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -16782.646% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -972.49% |
| Blueprint Medicines Corporation | 918.64 Million USD | 10.408% |
| CalciMedica, Inc. | 4.02 Million USD | -20332.696% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -4615.958% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -433.939% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -859.051% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -196.274% |
| Pulmatrix, Inc. | 15.96 Million USD | -5055.854% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -5117.961% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -3244.831% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -228.151% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1520.582% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 32.017% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2489.526% |
| Nutriband Inc. | 1.07 Million USD | -76182.742% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -7640.327% |
| Vor Biopharma Inc. | 59.1 Million USD | -1292.51% |
| Roivant Sciences Ltd. | 773.95 Million USD | -6.341% |
| Evogene Ltd. | 17.99 Million USD | -4474.925% |
| ProKidney Corp. | 29.21 Million USD | -2717.049% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1043.429% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -116644.517% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 56.428% |
| CorMedix Inc. | 11.91 Million USD | -6806.038% |
| BioLineRx Ltd. | 50.7 Million USD | -1523.267% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -450.672% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -830.597% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1574.116% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2541.952% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -4482.057% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -560.346% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -14456.579% |
| MediciNova, Inc. | 3.89 Million USD | -21049.115% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -4402.593% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -54613.906% |
| GeoVax Labs, Inc. | 3.51 Million USD | -23282.296% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -107.177% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2581.75% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 69.761% |
| Mereo BioPharma Group plc | 15.96 Million USD | -5056.177% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2537.829% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1302.476% |
| Absci Corporation | 58.3 Million USD | -1311.617% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4220.816% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2466.992% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1015.367% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -840.787% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2337.16% |
| Allakos Inc. | 74.79 Million USD | -1000.409% |
| Imunon, Inc. | 8.53 Million USD | -9548.157% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -3557.744% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -616.849% |
| BioAtla, Inc. | 48.98 Million USD | -1580.131% |
| NLS Pharmaceutics AG | 10.68 Million USD | -7606.117% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -29516.013% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -530.171% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -5689.863% |
| XOMA Corporation | 145.58 Million USD | -465.345% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2344.762% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1096.976% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2504.769% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1231.267% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1730.377% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1600.403% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -28576.969% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -9988.59% |
| Akari Therapeutics, Plc | 4.58 Million USD | -17854.385% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -4541.194% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 50.103% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -203666.452% |
| UroGen Pharma Ltd. | 243.52 Million USD | -237.968% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -156.326% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -29703.068% |
| Orgenesis Inc. | 35.53 Million USD | -2216.108% |
| Entera Bio Ltd. | 1.37 Million USD | -59583.031% |
| GH Research PLC | 6.7 Million USD | -12182.182% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -12003.368% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -4271.768% |
| Xencor, Inc. | 283.55 Million USD | -190.25% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -27465.927% |
| Replimune Group, Inc. | 113.21 Million USD | -626.968% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -21805.819% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -694.967% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -203666.452% |
| Portage Biotech Inc. | 4.45 Million USD | -18395.034% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -54613.906% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -3470.625% |
| OncoCyte Corporation | 49.29 Million USD | -1569.498% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -19795.282% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -103103.199% |
| Purple Biotech Ltd. | 10 Million USD | -8126.177% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -14124.49% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1337.329% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -6543.749% |
| HilleVax, Inc. | 78.9 Million USD | -943.01% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -16197.604% |
| Tharimmune, Inc. | 1.81 Million USD | -45244.801% |
| Genprex, Inc. | 3.25 Million USD | -25191.223% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2934.88% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -15618.659% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -399428.641% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -229444.998% |
| OKYO Pharma Limited | 7.42 Million USD | -10990.771% |
| Savara Inc. | 37.19 Million USD | -2112.919% |
| Curis, Inc. | 57.61 Million USD | -1328.572% |
| Daré Bioscience, Inc. | 26.32 Million USD | -3025.839% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1999.575% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -56896.468% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -3853.259% |
| BeiGene, Ltd. | 2.23 Billion USD | 63.155% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -3765.837% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -213.658% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -3768.708% |
| Erasca, Inc. | 78.61 Million USD | -946.964% |
| bluebird bio, Inc. | 424.62 Million USD | -93.825% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -125504.958% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 56.455% |
| DBV Technologies S.A. | 42.8 Million USD | -1822.965% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -125504.958% |
| Moderna, Inc. | 4.57 Billion USD | 81.998% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -11665.961% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -49599.819% |
| Molecular Templates, Inc. | 31.17 Million USD | -2540.368% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -4721.494% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -39.946% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -561.041% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2899.705% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2157.595% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1379.337% |
| MacroGenics, Inc. | 154.2 Million USD | -433.717% |
| RenovoRx, Inc. | 4.46 Million USD | -18328.773% |
| Adicet Bio, Inc. | 37.12 Million USD | -2117.212% |
| Prime Medicine, Inc. | 60.78 Million USD | -1254.112% |
| Aditxt, Inc. | 28.53 Million USD | -2784.627% |
| Adagene Inc. | 45.16 Million USD | -1722.097% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -455364.552% |
| Quantum-Si incorporated | 26.63 Million USD | -2990.492% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -17.986% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -26951.628% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -615.92% |
| SciSparc Ltd. | 1.59 Million USD | -51500.564% |
| Vericel Corporation | 127.7 Million USD | -544.477% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -14689.662% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -864.207% |
| Generation Bio Co. | 171.63 Million USD | -379.537% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -7025.792% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1867.51% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -225.697% |
| Invivyd, Inc. | 51.71 Million USD | -1491.532% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -794.82% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -12551.764% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -990.162% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -80510.088% |
| 2seventy bio, Inc. | 310.12 Million USD | -165.385% |
| ADMA Biologics, Inc. | 193.97 Million USD | -324.294% |
| Clene Inc. | 38.95 Million USD | -2012.986% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2177.785% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -220.275% |
| GeoVax Labs, Inc. | 3.51 Million USD | -23282.296% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -332.574% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -6657.404% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -314.996% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -6649.016% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1610.688% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1457.558% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -122.528% |
| Evaxion Biotech A/S | 17.61 Million USD | -4571.661% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -411.424% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -437.274% |
| Trevena, Inc. | 48.26 Million USD | -1605.335% |
| Surrozen, Inc. | 8.14 Million USD | -10004.715% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -3711.202% |
| Cingulate Inc. | 10.36 Million USD | -7843.632% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -29828.327% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -2106.985% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -22847.844% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -6158.776% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -159.466% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -3212.121% |
| Clearmind Medicine Inc. | 3.61 Million USD | -22698.537% |
| Kronos Bio, Inc. | 54.2 Million USD | -1418.476% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1649.525% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3516.163% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -4000.588% |
| Statera Biopharma, Inc. | 22.67 Million USD | -3529.443% |
| ImmunityBio, Inc. | 1.09 Billion USD | 24.52% |
| Korro Bio, Inc. | 51.75 Million USD | -1490.333% |
| Kineta, Inc. | 7.22 Million USD | -11296.137% |
| BioVie Inc. | 9.7 Million USD | -8382.972% |
| Codexis, Inc. | 49.94 Million USD | -1547.838% |
| Celularity Inc. | 102.92 Million USD | -699.608% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -755.122% |
| Celcuity Inc. | 51.45 Million USD | -1499.665% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -238325.06% |
| Cibus, Inc. | 206.11 Million USD | -299.302% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1837.679% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -3024.754% |
| IN8bio, Inc. | 8.77 Million USD | -9282.456% |
| Kodiak Sciences Inc. | 213.59 Million USD | -285.329% |
| Annexon, Inc. | 47.11 Million USD | -1646.74% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -819.164% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -754.013% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -5912.338% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 68.386% |
| Eyenovia, Inc. | 19.78 Million USD | -4060.856% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -364.762% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -10615.128% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -3315.2% |
| Arcellx, Inc. | 339.75 Million USD | -142.244% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -6817.373% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -235.191% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -8506.389% |
| Moolec Science SA | 13.94 Million USD | -5801.814% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1807.279% |
| Geron Corporation | 146.12 Million USD | -463.229% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1528.728% |
| Royalty Pharma plc | 6.29 Billion USD | 86.931% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1969.16% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -279455.784% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -33352.629% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -335.106% |
| Humacyte, Inc. | 114.67 Million USD | -617.693% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2733.048% |
| 89bio, Inc. | 59.96 Million USD | -1272.561% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -3010.112% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -68715.134% |
| Genelux Corporation | 8.42 Million USD | -9674.691% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -11904.507% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -503.752% |
| Notable Labs, Ltd. | 4.42 Million USD | -18491.123% |
| Liquidia Corporation | 73.13 Million USD | -1025.31% |
| Mustang Bio, Inc. | 17.61 Million USD | -4571.258% |
| Immunovant, Inc. | 48.95 Million USD | -1581.195% |
| Quantum-Si incorporated | 26.63 Million USD | -2990.492% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -2044.254% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -26423.655% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1014.294% |
| Acasti Pharma Inc. | 11.55 Million USD | -7021.476% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -3540.476% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -30176.162% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -2131.822% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -60290.64% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -13401.132% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -3213.988% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -3449.987% |
| PepGen Inc. | 34.63 Million USD | -2276.567% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -6677.248% |
| United Therapeutics Corporation | 1.18 Billion USD | 30.382% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -11684.493% |
| Solid Biosciences Inc. | 38.45 Million USD | -2040.072% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -9517.979% |
| Immuneering Corporation | 12 Million USD | -6753.803% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -262129.734% |
| Silo Pharma, Inc. | 1.56 Million USD | -52346.615% |
| Belite Bio, Inc | 4.21 Million USD | -19444.74% |
| XOMA Corporation | 145.58 Million USD | -465.345% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -33797.405% |
| Bionomics Limited | 10.15 Million USD | -8001.699% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -3729.645% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3491.974% |
| uniQure N.V. | 624.01 Million USD | -31.892% |
| Cassava Sciences, Inc. | 14.19 Million USD | -5698.02% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -455364.552% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -383.611% |
| Forte Biosciences, Inc. | 3.66 Million USD | -22350.327% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -315741.402% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -12098.444% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -10615.128% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -4634.678% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -7687.935% |
| Altimmune, Inc. | 16.54 Million USD | -4875.691% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -33.24% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3491.974% |
| Compugen Ltd. | 55.77 Million USD | -1375.623% |
| Peak Bio, Inc. | 20.75 Million USD | -3865.762% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -645.072% |
| Benitec Biopharma Inc. | 4.96 Million USD | -16486.638% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -421.423% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -994.832% |
| Zura Bio Limited | 21.29 Million USD | -3765.438% |
| PolyPid Ltd. | 17.46 Million USD | -4611.638% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -632.239% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -994.832% |
| Instil Bio, Inc. | 99.8 Million USD | -724.67% |
| argenx SE | 444.95 Million USD | -84.971% |
| Immunome, Inc. | 28.65 Million USD | -2771.9% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -9772.004% |
| Verona Pharma plc | 58.84 Million USD | -1298.734% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -5586.651% |
| Shattuck Labs, Inc. | 14.85 Million USD | -5438.926% |
| CervoMed Inc. | 2.59 Million USD | -31606.827% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -16786.11% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -6362.225% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -7712.33% |
| Moolec Science SA | 13.94 Million USD | -5801.814% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -35019.59% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1380.393% |
| AnaptysBio, Inc. | 364.28 Million USD | -125.929% |
| Design Therapeutics, Inc. | 11.95 Million USD | -6783.816% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -6388.718% |
| NeurAxis, Inc. | 1.91 Million USD | -42928.819% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -2014.234% |
| Lumos Pharma, Inc. | 13.33 Million USD | -6072.872% |
| Achilles Therapeutics plc | 19.08 Million USD | -4211.987% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -5586.651% |
| 180 Life Sciences Corp. | 5.38 Million USD | -15177.466% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -3389.187% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3516.163% |
| Nutriband Inc. | 1.07 Million USD | -76182.742% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2589.813% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -5571.759% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -105.104% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2434.503% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -6207.173% |
| Palisade Bio, Inc. | 2.73 Million USD | -29948.521% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -15567.79% |
| Beam Therapeutics Inc. | 478.38 Million USD | -72.043% |
| Neurogene Inc. | 36.54 Million USD | -2151.851% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -106.817% |
| AEON Biopharma, Inc. | 159.88 Million USD | -414.75% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1627.238% |
| Sesen Bio, Inc. | 30.98 Million USD | -2556.303% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -3070.252% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -10726.172% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -320.475% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -328.534% |
| Athira Pharma, Inc. | 30.05 Million USD | -2638.227% |
| Vaccinex, Inc. | 5.94 Million USD | -13751.043% |
| HCW Biologics Inc. | 15.05 Million USD | -5367.925% |
| XOMA Corporation | 145.58 Million USD | -465.345% |
| Nektar Therapeutics | 267.04 Million USD | -208.197% |
| Arvinas, Inc. | 644.6 Million USD | -27.681% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -4541.194% |
| Merus N.V. | 102.15 Million USD | -705.698% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -462.37% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -765.253% |
| Rezolute, Inc. | 11.73 Million USD | -6914.053% |
| Clene Inc. | 38.95 Million USD | -2012.986% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -28804.783% |
| BeyondSpring Inc. | 48.26 Million USD | -1605.088% |
| Synlogic, Inc. | 32.89 Million USD | -2401.988% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -5532.17% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -50268.972% |
| Peak Bio, Inc. | 20.75 Million USD | -3865.762% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1196.946% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1972.39% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -118.516% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -726.592% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -190096.337% |
| MannKind Corporation | 721.36 Million USD | -14.093% |
| Ikena Oncology, Inc. | 22.33 Million USD | -3584.929% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -39354.89% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -702.251% |
| Gossamer Bio, Inc. | 249.14 Million USD | -230.339% |
| CohBar, Inc. | 1.03 Million USD | -79524.491% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -7599.775% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4220.816% |
| Legend Biotech Corporation | 589.93 Million USD | -39.512% |
| Mural Oncology plc | 37.92 Million USD | -2069.977% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -520.517% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -35756.643% |
| Disc Medicine, Inc. | 22.87 Million USD | -3497.941% |
| Champions Oncology, Inc. | 28.03 Million USD | -2835.72% |
| REGENXBIO Inc. | 262.22 Million USD | -213.86% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -24399.636% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -6466.371% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -6027.545% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -3781.297% |
| Vaxart, Inc. | 34.02 Million USD | -2318.895% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -3936.58% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2784.594% |
| Cellectis S.A. | 249.57 Million USD | -229.772% |
| Longeveron Inc. | 5.33 Million USD | -15321.192% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1868.074% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 65.782% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1263.353% |
| Revolution Medicines, Inc. | 262.39 Million USD | -213.658% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -38961.652% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -9441.259% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -6874.231% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -5760.778% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -38162.622% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 84.018% |
| Denali Therapeutics Inc. | 122.96 Million USD | -569.331% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -14689.662% |
| Veru Inc. | 32.81 Million USD | -2408.263% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -11881.788% |
| Cingulate Inc. | 10.36 Million USD | -7843.632% |
| Passage Bio, Inc. | 39.26 Million USD | -1996.248% |
| Context Therapeutics Inc. | 4.19 Million USD | -19534.66% |
| Exicure, Inc. | 8.54 Million USD | -9527.196% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2689.172% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -7748.837% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -3634.082% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -404.969% |
| Nuvalent, Inc. | 31.82 Million USD | -2486.271% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -12837.398% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1205.939% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -4472.383% |
| OmniAb, Inc. | 87.4 Million USD | -841.681% |
| Anew Medical, Inc. | 8.24 Million USD | -9886.036% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -2049.513% |
| Lipocine Inc. | 2.63 Million USD | -31174.507% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -3032.723% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1946.725% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2989.238% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -855.3% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -15138.456% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -894.633% |
| Ocugen, Inc. | 23.98 Million USD | -3331.718% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1673.502% |
| Q32 Bio Inc. | 233.12 Million USD | -253.037% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -8978.193% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1438.314% |
| Equillium, Inc. | 27.95 Million USD | -2843.91% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -298.384% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -14527.297% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -13319.75% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -423.136% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1085.357% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -8151.578% |
| Dominari Holdings Inc. | 4.63 Million USD | -17656.828% |
| Edesa Biotech, Inc. | 1.84 Million USD | -44590.077% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2683.607% |
| Bio-Techne Corporation | 744.34 Million USD | -10.572% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -552.685% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -138.936% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1928.414% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2742.245% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -791.11% |
| Nkarta, Inc. | 105.6 Million USD | -679.384% |
| BioCardia, Inc. | 4.59 Million USD | -17830.915% |
| Iterum Therapeutics plc | 32.66 Million USD | -2419.837% |